📊 IOSP Key Takeaways
Is Innospec Inc.. (IOSP) a Good Investment?
Innospec maintains a fortress balance sheet with zero debt and strong liquidity (2.98x current ratio), but faces headwinds from declining revenue (-3.7% YoY) and extremely weak capital returns (2.3% ROE, 1.7% ROA). The 227.5% earnings surge amid revenue decline raises questions about earnings quality and sustainability.
Innospec shows solid fundamental quality through a debt-free balance sheet, strong liquidity, and consistent free cash flow generation. However, revenue declined year over year and the large jump in net income appears much stronger than operating profit growth, which raises some caution on earnings quality and the durability of recent profit improvement. The company looks financially healthy, but fundamental momentum is not strong enough to justify a more aggressive rating.
Why Buy Innospec Inc.. Stock? IOSP Key Strengths
- Zero long-term debt with $289.1M cash position provides significant financial flexibility and downside protection
- Strong liquidity metrics (current ratio 2.98x, quick ratio 2.02x) indicate robust ability to meet obligations
- Net income surged 227.5% YoY and diluted EPS grew 228.9%, suggesting meaningful operational improvements or cost reductions
- Debt-free balance sheet with $292.5M in cash and no long-term debt
- Healthy liquidity profile with 2.79x current ratio and 1.88x quick ratio
- Positive free cash flow of $120.7M with solid cash generation relative to earnings
IOSP Stock Risks: Innospec Inc.. Investment Risks
- Revenue declining 3.7% YoY with zero free cash flow generation (operating cash flow equals capex exactly) indicates stagnation and unsustainable capital allocation
- Dangerously low returns on capital - ROE of 2.3% and ROA of 1.7% demonstrate poor capital efficiency despite being debt-free
- Earnings quality questionable - massive net income improvement contradicts revenue decline, suggesting one-time gains or prior-year charges rather than sustainable operational leverage
- Revenue declined 3.7% year over year, indicating weak top-line momentum
- Net income grew far faster than operating income, suggesting possible non-operating or non-recurring earnings support
- Profitability is positive but still moderate, with 7.3% operating margin and 8.8% ROE
Key Metrics to Watch
- Free cash flow trend - must turn positive to validate business sustainability
- Revenue growth trajectory - need evidence of stabilization or recovery to confirm end of decline
- Return on equity and operating margins - fundamental improvement needed to justify capital retention
- Revenue growth and segment demand recovery
- Operating margin and free cash flow conversion
Innospec Inc.. (IOSP) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.98x current ratio provides a solid financial cushion.
IOSP Profit Margin, ROE & Profitability Analysis
IOSP vs Materials Sector: How Innospec Inc.. Compares
How Innospec Inc.. compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Innospec Inc.. Stock Overvalued? IOSP Valuation Analysis 2026
Based on fundamental analysis, Innospec Inc.. has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Innospec Inc.. Balance Sheet: IOSP Debt, Cash & Liquidity
IOSP Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Innospec Inc..'s revenue has grown significantly by 29% over the 5-year period, indicating strong business expansion. The most recent EPS of $5.56 reflects profitable operations.
IOSP Revenue Growth, EPS Growth & YoY Performance
IOSP Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $440.8M | $30.4M | $1.22 |
| Q3 2025 | $441.9M | N/A | $0.52 |
| Q2 2025 | $435.0M | N/A | $0.94 |
| Q1 2025 | $440.8M | N/A | $1.31 |
| Q3 2024 | $443.4M | N/A | $1.33 |
| Q2 2024 | $435.0M | N/A | $1.16 |
| Q1 2024 | $500.2M | N/A | $1.33 |
| Q3 2023 | $464.1M | N/A | $1.55 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Innospec Inc.. Dividends, Buybacks & Capital Allocation
IOSP SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Innospec Inc.. (CIK: 0001054905)
📋 Recent SEC Filings
❓ Frequently Asked Questions about IOSP
What is the AI rating for IOSP?
Innospec Inc.. (IOSP) has a Combined AI Rating of HOLD from Claude (HOLD) and ChatGPT (HOLD) with 73% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are IOSP's key strengths?
Claude: Zero long-term debt with $289.1M cash position provides significant financial flexibility and downside protection. Strong liquidity metrics (current ratio 2.98x, quick ratio 2.02x) indicate robust ability to meet obligations. ChatGPT: Debt-free balance sheet with $292.5M in cash and no long-term debt. Healthy liquidity profile with 2.79x current ratio and 1.88x quick ratio.
What are the risks of investing in IOSP?
Claude: Revenue declining 3.7% YoY with zero free cash flow generation (operating cash flow equals capex exactly) indicates stagnation and unsustainable capital allocation. Dangerously low returns on capital - ROE of 2.3% and ROA of 1.7% demonstrate poor capital efficiency despite being debt-free. ChatGPT: Revenue declined 3.7% year over year, indicating weak top-line momentum. Net income grew far faster than operating income, suggesting possible non-operating or non-recurring earnings support.
What is IOSP's revenue and growth?
Innospec Inc.. reported revenue of $453.2M.
Does IOSP pay dividends?
Innospec Inc.. pays dividends, with $42.4M distributed to shareholders in the trailing twelve months.
Where can I find IOSP SEC filings?
Official SEC filings for Innospec Inc.. (CIK: 0001054905) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is IOSP's EPS?
Innospec Inc.. has a diluted EPS of $1.22.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is IOSP a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Innospec Inc.. has a HOLD rating with 73% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is IOSP stock overvalued or undervalued?
Valuation metrics for IOSP: ROE of 2.3% (sector avg: 14%), net margin of 6.7% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy IOSP stock in 2026?
Our dual AI analysis gives Innospec Inc.. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is IOSP's free cash flow?
Innospec Inc..'s operating cash flow is $17.6M, with capital expenditures of $17.6M. FCF margin is 0.0%.
How does IOSP compare to other Materials stocks?
Vs Materials sector averages: Net margin 6.7% (avg: 10%), ROE 2.3% (avg: 14%), current ratio 2.98 (avg: 1.6).